Skoči na glavni sadržaj

Sažetak sa skupa

Non-Aromatic Naphthalane: A Future Remedy For Oral Mucosal Lesions

I. Alajbeg
A. Cekić-Arambašin
A. Alajbeg
S. Ivanković
M. Jurin
G. Krnjević-Pezić
P. Vrgožić
I. Dobrić


Puni tekst: hrvatski pdf 51 Kb

str. 295-295

preuzimanja: 578

citiraj

Puni tekst: engleski pdf 56 Kb

str. 295-296

preuzimanja: 632

citiraj


Sažetak

The purpose of this lecture is to summarize data obtained from several experiments conducted by authors, regarding the composition of special Croatian petrol fraction reffered to as “Non Aromatic- Very rich in Steranes” (NAVS) naphthalane, as well as its potent-inflammatory and cellular growth controlling effect. NAVS is derived from ordinary brown naphthalane, particulaly rich in steranes, that has been famous for decades in the treatment of psoriasis vulgaris (Naftalan, Ivanić Grad, Croatia). NAVS was prepared by removing virtually all of its original polycyclic aromatic content (some of them are carcinogenic), which resulted in completely colourless transparent oil with a pleasant scent. Steranes were preserved and concentrated during the de-aromatisation process, as was proven by means of GC and GC-MS. These geogenic steranes have molecular skeletons analogous to bioactive compounds, such as corticosteroids and vitamin D. Due to these structure similarities, we can explain the beneficial affects in treating psoriatic patients with NAVS, which yielded promising results. NAVS treatment did not affect either haematological or biochemical findings. Further studies established In vitro dose dependant inhibition of planocellular carcinoma (SCC VII) cell proliferation, withhout interfering with nonmalignant fibroblast (L929) cells, thus showing selectivity in cell proliferation control. In vivo results showed marked delay in tumour growth. A rationale for that, besides cell proliferation control, authors see also in the antineoangiogenetic activity of NAVS (similar to vitamin D), wich is yet to bi proved through immunohistochemical studies. Future studies are planned and oral planocellular carsinoma animal models are being developed in order to introduce NAVS in the treatment of different conditions of oral mucosa, because the preparation is not only effective, but also highly applicable in oral tissues, due to its superior organoleptic properties.

Ključne riječi

Hrčak ID:

2729

URI

https://hrcak.srce.hr/2729

Datum izdavanja:

15.9.2003.

Podaci na drugim jezicima: hrvatski

Posjeta: 2.471 *